SCHEMBL17486305

SCHEMBL17486305

CC(=O)c1cc(-c2nc(-c3ccccc3)nc(N(c3ccccc3)c3ccccc3)n2)cnc1-c1ccc2c(c1)C(C)(C)C(C)(C)C2(C)C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.33
CSNK1G2 P78368 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
MAP4K5 Q9Y4K4 1/20 0.33
ADORA2A P29274 4/20 0.33
ADORA1 P30542 4/20 0.33
ADORA3 P0DMS8 3/20 0.33
ALDH1A1 P00352 6/20 0.32
MEN1 O00255 5/20 0.32
KMT2A Q03164 5/20 0.32
MAPT P10636 4/20 0.32
HPGD P15428 4/20 0.32
NPSR1 Q6W5P4 2/20 0.32
CYP2C19 P33261 2/20 0.32
KDM4E B2RXH2 2/20 0.32
RXFP1 Q9HBX9 1/20 0.32
PTGDR2 Q9Y5Y4 2/20 0.32
PRNP P04156 1/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17486084 0.83 HSD17B1 (0.34) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL17486105 0.79 MAPT (0.33) ALDH1A1MEN1KMT2AMAPTNPSR1
SCHEMBL17486306 0.78 TRPV1 (0.34) ADORA3RARARARBRARGNPC1
SCHEMBL20805503 0.75 MAPT (0.30) MEN1KMT2AMAPT
SCHEMBL17486054 0.73 NPC1 (0.37) ALDH1A1KMT2AHPGDKDM4ERARA
SCHEMBL17486270 0.73 MEN1 (0.38) CLK4ALDH1A1MEN1KMT2AMAPT
SCHEMBL17486132 0.73 ALDH1A1 (0.40) ADORA2AADORA1ALDH1A1MEN1KMT2A
SCHEMBL17486227 0.73 HSD17B1 (0.41) ADORA2AADORA1ALDH1A1MEN1KMT2A
SCHEMBL17486017 0.72 SMN1; SMN2 (0.33) ALDH1A1HPGDKDM4ERXFP1PTGDR2
SCHEMBL17485975 0.72 HSD17B1 (0.43) ALDH1A1MEN1KMT2AMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174890-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-03-13 EP disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
WO-2016015815-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250353-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 MAP4K4 3003/4885CSNK1G2 3706/4885CLK4 2599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.